Valuation: Net Medical Xpress Solutions, Inc.

Market Cap 1.07M 959K 886K 803K 1.5M 102M 1.53M 10.66M 4.22M 53.4M 4.03M 3.94M 168M P/E 2015
32.9x
P/E 2016 -5.75x
Enterprise Value 827K 738K 682K 618K 1.16M 78.47M 1.18M 8.21M 3.25M 41.11M 3.1M 3.04M 130M EV / Sales 2015
1.04x
EV / Sales 2016 0.65x
Free-Float
100%
Yield 2015 *
-
Yield 2016 -
1 day+0.14%
1 week-0.14%
Current month-0.14%
1 month-0.14%
3 months-0.14%
Current year+133.33%
Current year 0
Extreme 0.0004
0
1 year 0
Extreme 1.0E-6
0
3 years 0
Extreme 1.0E-6
0.03
5 years 0
Extreme 1.0E-6
0.75
10 years 0
Extreme 0
0.75
Manager TitleAgeSince
President - 2019-06-25
Director TitleAgeSince
Director/Board Member 64 2002-12-31
Director/Board Member 84 2004-12-31
Director/Board Member - 2018-02-28
Change 5-day change 1-year change 3-year change Capi.($)
+0.14%-0.14%+600.00%-97.23% 26.4K
+0.66%-0.86%+0.76%+59.27% 3,870B
+0.29%+5.76%+9.01%+1,114.51% 471B
+0.49%-1.61%-54.95%+21.71% 381B
+7.22%+11.27%+76.98%+209.18% 284B
-0.44%+6.53%-9.48%+73.01% 278B
+8.25%+13.27%+97.38%+475.32% 244B
+1.25%+11.97%-15.37%+46.81% 162B
+4.05%+6.42%+111.93%+220.84% 128B
-2.49%+7.59%-25.50%-51.18% 105B
Average +2.01%+4.59%+79.08%+207.22% 592.38B
Weighted average by Cap. +0.97%+1.10%+6.48%+167.00%

Financials

2015 2016
Net sales 4.22M 3.77M 3.48M 3.16M 5.91M 401M 6M 41.91M 16.59M 210M 15.84M 15.51M 662M 3.04M 2.72M 2.51M 2.28M 4.26M 289M 4.33M 30.23M 11.97M 151M 11.43M 11.18M 477M
Net income 151K 135K 125K 113K 211K 14.33M 215K 1.5M 593K 7.51M 567K 555K 23.68M -344K -307K -284K -257K -481K -32.66M -489K -3.41M -1.35M -17.11M -1.29M -1.26M -53.94M
Net Debt -340K -304K -280K -254K -476K -32.28M -483K -3.38M -1.34M -16.91M -1.28M -1.25M -53.31M -247K -221K -204K -185K -345K -23.45M -351K -2.45M -971K -12.28M -927K -907K -38.73M
Logo Net Medical Xpress Solutions, Inc.
Net Medical Xpress Solutions, Inc. focuses on the development of artificial intelligence software named PrivateAI (Private Eye), developing clinical trials, and expanding immune defense products to different markets. The Company is also focusing on productizing hand-labeled image data for use in artificial intelligence training, verification, and validation of custom models. It focuses on artificial intelligence for medical research, clinical trials, and Food and Drug Administration (FDA) compliance, which includes cybersecurity audit products designed to meet the FDA's new mandates for connected devices. Through its subsidiary, Immunity Science, Inc., the Company provides a variety of over-the-counter vitamins, supplements, air purifiers, nasal sprays, and drug-free pain patches. It offers its products through the Website www.immunityscience.store direct to consumers. In addition, products are available from distribution centers at retail locations.
Employees
23
  1. Stock Market
  2. Stocks
  3. NMXS Stock